Global shifts in transfusion-dependent thalassemia (TDT): Epidemiological trends, regional disparities, and prevention strategies (pre-2010 vs. 2015–2021)

Global shifts in transfusion-dependent thalassemia (TDT): Epidemiological trends, regional disparities, and prevention strategies (pre-2010 vs. 2015–2021)

Authors

  • Ashraf T Soliman Department of Pediatrics, Hamad General Hospital, Doha, Qatar
  • Vincenzo De Sanctis Pediatric and Adolescent Outpatient Clinic, Quisisana Hospital, Ferrara, Italy

Keywords:

Global Shifts , beta thalassemia , Epidemiological trends, regional disparities, prevention strategies

References

1. De Sanctis V, Soliman AT. Endocrine complications in thalassemia major: growth, GH–IGF-I axis, and puberty. Endo-Thal Riv Ital Med Adolesc. 2020;18(3):1-4.

2. Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders. Expert Rev Hematol. 2010;3(6):103–17. doi: 10.1586/EHM.10.92.

3. Cousens NE, Gaff CL, Metcalfe SA, Delatycki MB. Carrier screening for beta-thalassaemia: a review of international practice. Eur J Hum Genet. 2010;18(10):1077–83. doi: 10.1038/ejhg.2010.71.

4. Tuo Y, Chan K, Li J, Wang Y, Tanaka Y, et al. Global, regional, and national burden of thalassemia, 1990–2021. eClinicalMedicine. 2024;73:102123. doi: 10.1016/j.eclinm.2024.102123.

5. Kattamis A, Forni GL, Aydinok Y, Viprakasit V. Changing patterns in the epidemiology of thalassemia. Br J Haematol. 2020;190(3):323–34. doi: 10.1111/bjh.16783.

6. Forni GL, Cappellini MD, Taher A, et al. Global burden and unmet needs in the treatment of transfusion-dependent β-thalassemia. Front Hematol. 2023;8:1187681. doi: 10.3389/frhem.2023.1187681.

7. Li B, Liu Y, Chen Q, et al. Prevalence, mutation distribution, and economic burden of thalassemia in China: a systematic review and regional analysis. Front Public Health. 2025;13:11972477. doi: 10.3389/fpubh.2025.11972477.

8. El-Beshlawy A, Elalfy MS. Management of transfusion-dependent β-thalassemia (TDT): A practical overview. Transfus Apher Sci. 2024;63(2):103845. doi: 10.1016/j.transci.2024.103845.

9. World Health Organization, Regional Office for South-East Asia. Prevalence and burden of thalassaemia syndromes in Southeast Asia. New Delhi: WHO Regional Office for South-East Asia; 2021.

10. Musallam KM, Rivella S, Taher AT, et al. Epidemiology of clinically significant forms of α- and β-thalassemia: A systematic literature review. Am J Hematol. 2023;98(1):24–41. doi: 10.1002/ajh.26703.

11. Modell B, Khan M, Darlison M, et al. A national register for surveillance of inherited disorders: beta thalassaemia in the United Kingdom. Bull World Health Organ. 2001;79(11):1006–1013.

12. Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev. 2003;17(1):43–53. doi:10.1016/S0268-960X(02)00051-2.

13. Angastiniotis M, Eleftheriou A, Galanello R, et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest. 2007;67(1):39–69. doi:10.1080/00365510601084850.

14. Voskaridou E, Ladis V, Kattamis A, et al. A national registry of hemoglobinopathies in Greece: demographic data and trends. Ann Hematol. 2012;91(9):1451–1458. doi:10.1007/s00277-012-1465-7.

15. Aguilar Martinez P, Angastiniotis M, Eleftheriou A, et al. Haemoglobinopathies in Europe: health & migration policy perspectives. Orphanet J Rare Dis. 2014;9:97. doi:10.1186/1750-1172-9-97.

16. Hadipour Dehshal M, Tabrizi Namini M, Ahmadvand A, et al. Evaluation of the national prevention program in Iran, 2007–2009: accomplishments and challenges. Hemoglobin. 2014;38(3):179–187. doi:10.3109/03630269.2014.893530.

17. Kountouris P, Kousiappa I, Papasavva T, et al. The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective study. Sci Rep. 2016;6:26371. doi:10.1038/srep26371.

Downloads

Published

27-02-2026

Issue

Section

LETTERS TO THE EDITOR AND CORRESPONDENCE

How to Cite

1.
Soliman AT, De Sanctis V. Global shifts in transfusion-dependent thalassemia (TDT): Epidemiological trends, regional disparities, and prevention strategies (pre-2010 vs. 2015–2021). Acta Biomed. 2026;97(1):17741. doi:10.23750/abm.2026.17741